Figures & data
Table 1. Diagnostic performance of CTA, FFRCT, and different noninvasive ischemia testing modalities in patients with stable CAD and intermediate range coronary artery stenosis determined by CTA. All prospective studies measured FFR as the reference standard
Nørgaard BL, Leipsic J, Gaur S, et al. Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial. J Am Coll Cardiol. 2014;63(12): 1145–1155. Nissen L, Winther S, Westra J, et al. Diagnosing coronary artery disease after a positive coronary computed tomographyangiography: the Dan-NICAD open label, parallel, head to head, randomized controlled diagnostic accuracy trial of cardiovascular magnetic resonance and myocardial perfusion scintigraphy. Eur Heart J Cardiovasc Imaging. 2018;19(4):369–377. Driessen RS, Danad I, Stuijfzand WJ, et al. Comparison of coronary computed tomography angiography, fractional flow reserve, and perfusion imaging for ischemia diagnosis. J Am Coll Cardiol. 2019;73(2):61–173. Danad I, Raijmakers PG, Driessen RS, et al. Comparison of coronary CT angiography, SPECT, PET, and hybrid imaging for diagnosis of ischemic heart disease determined by fractional flow reserve. JAMA Cardiol. 2017;2(10):1100–1107. Sand NPR, Veien KT, Nielsen SS, et al. Prospective comparison of FFR derived from coronary CT angiography with SPECT perfusion imaging in stable coronary artery disease: the ReASSES Study. JACC Cardiovasc Imaging. 2018;11(11):1640–1650.